Videos Library
Cell & gene therapies: A global perspective of HTA, funding & reimbursement challenges
Related topics:
Pharmaceutical/Biotech, Market Access & HEOR, Global (non-specific)
Overview
- Overview of cell & gene therapies.
- Health technology assessment & cost effectiveness challenges.
- Who pays? Healthcare system determinants of funding / reimbursement.
- Affordability: Pricing and budget impact challenges.
- Lessons learned: Early case studies.
Speaker
Neil Palmer
President & Principal Consultant
PDCI Market Access Inc.
Subscribe or unlock this video to download the presentation slides. If you already have an account, please log in.
REMINDER
This is the presenters’ personal opinion and does not necessarily represent true facts, the official views or policy of their organisation, nor the views of Evidence Life Science.
Sponsor
